US Patent

US9737561 — Topical gels and methods of using the same

Method of Use · Assigned to Novan Inc · Expires 2030-08-20 · 4y remaining

Vulnerability score 81/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects topical gels that release nitric oxide and methods of using them to treat wounds and other skin ailments.

USPTO Abstract

Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments.

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3802`	—	berdazimer-sodium

Patent Metadata

Patent number: US9737561
Jurisdiction: US
Classification: Method of Use
Expires: 2030-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Novan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.